Kazuyuki Yamagata

Kazuyuki Yamagata

Auto-generated profile, based on publicly available information

Kazuyuki Yamagata

Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Molecular Cell
Verified
Journal Article
Closed access
KYKazuyuki Yamagata
Kazuyuki Yamagata
HDHiroaki Daitoku
Hiroaki Daitoku
YTYuta Takahashi
Yuta Takahashi
KNKana Namiki
Kana Namiki
KHKoji Hisatake
Koji Hisatake
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu

1 May 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KYKazuyuki Yamagata
Kazuyuki Yamagata
HDHiroaki Daitoku
Hiroaki Daitoku
YSYoko Shimamoto
Yoko Shimamoto
HMHitomi Matsuzaki
Hitomi Matsuzaki
KHKeiko Hirota
Keiko Hirota
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu
Bile acid homeostasis is tightly controlled by the feedback mechanism in which an atypical orphan nuclear receptor (NR) small heterodimer partner (SHP) inactivates several NRs such as liver receptor homologue-1 and hepatocyte nuclear factor 4. Although NRs have been implicated in the transcriptional regulation of gluconeogenic genes, the effect of bile acids on gluconeogenic gene expression remained unknown. Here, we report that bile acids inhibit the expression of gluconeogenic genes, including glucose-6-phosphatase (G6Pase), phosphoenolpyruvate carboxykinase, and fructose 1,6-bis phosphatase in an SHP-dependent fashion. Cholic acid diet decreased the mRNA levels of these gluconeogenic enzymes, whereas those of SHP were increased. Reporter assays demonstrated that the promoter activity of phosphoenolpyruvate carboxykinase and fructose 1,6-bis phosphatase via hepatocyte nuclear factor 4, or that of G6Pase via the forkhead transcription factor Foxo1, was down-regulated by treatment with chenodeoxicholic acid and with transfected SHP. Remarkably, Foxo1 interacted with SHP in vivo and in vitro, which led to the repression of Foxo1-mediated G6Pase transcription by competition with a coactivator cAMP response element-binding protein-binding protein. These findings reveal a novel mechanism by which bile acids regulate gluconeogenic gene expression via an SHP-dependent regulatory pathway.

1 March 2003 in Diabetes
Verified
Journal Article
Closed access
PDF file
HDHiroaki Daitoku
Hiroaki Daitoku
KYKazuyuki Yamagata
Kazuyuki Yamagata
HMHitomi Matsuzaki
Hitomi Matsuzaki
MHMitsutoki Hatta
Mitsutoki Hatta
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu
Peroxisome proliferator–activated receptor-γ coactivator-1 (PGC-1) plays a major role in mediating hepatic gluconeogenesis in response to starvation, during which PGC-1 is induced by the cyclic AMP response element binding protein. Although it is observed that insulin counteracts PGC-1 transcription, the mechanism by which insulin suppresses the transcription of PGC-1 is still unclear. Here, we show that forkhead transcription factor FKHR contributes to mediating the effects of insulin on PGC-1 promoter activity. Reporter assays demonstrate that insulin suppresses the basal PGC-1 promoter activity and that coexpression of protein kinase (PK)-B mimics the effect of insulin in HepG2 cells. Insulin response sequences (IRSs) are addressed in the PGC-1 promoter as the direct target for FKHR in vivo. Coexpression of FKHR stimulates the PGC-1 promoter activity via interaction with the IRSs, while coexpression of FKHR (3A), in which the three putative PKB sites in FKHR are mutated, mainly abolishes the suppressive effect of PKB. Whereas deletion of the IRSs prevents the promoter stimulation by FKHR, that activity is still partially inhibited by insulin. These results indicate that signaling via PKB to FKHR can partly account for the effect of insulin to regulate the PGC-1 promoter activity via the IRSs.

28 March 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JSJun-Ichi Sakamaki
Jun-Ichi Sakamaki
HDHiroaki Daitoku
Hiroaki Daitoku
KUKatsuya Ueno
Katsuya Ueno
AHAyano Hagiwara
Ayano Hagiwara
KYKazuyuki Yamagata
Kazuyuki Yamagata
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu
Protein arginine methylation is a common posttranslational modification catalyzed by a family of the protein arginine methyltransferases (PRMTs). We have previously reported that PRMT1 methylates Forkhead box O transcription factors at two arginine residues within an Akt consensus phosphorylation motif (RxRxxS/T), and that this methylation blocks Akt-mediated phosphorylation of the transcription factors. These findings led us to hypothesize that the functional crosstalk between arginine methylation and phosphorylation could be extended to other Akt target proteins as well as Forkhead box O proteins. Here we identify BCL-2 antagonist of cell death (BAD) as an additional substrate for PRMT1 among several Akt target proteins. We show that PRMT1 specifically binds and methylates BAD at Arg-94 and Arg-96, both of which comprise the Akt consensus phosphorylation motif. Consistent with the hypothesis, PRMT1-mediated methylation of these two arginine residues inhibits Akt-mediated phosphorylation of BAD at Ser-99 in vitro and in vivo. We also demonstrate that the complex formation of BAD with 14-3-3 proteins, which occurs subsequent to Akt-mediated phosphorylation, is negatively regulated by PRMT1. Furthermore, PRMT1 knockdown prevents mitochondrial localization of BAD and its binding to the antiapoptotic BCL-X L protein. BAD overexpression causes an increase in apoptosis with concomitant activation of caspase-3, whereas PRMT1 knockdown significantly suppresses these apoptotic processes. Taken together, our results add a new dimension to the complexity of posttranslational BAD regulation and provide evidence that arginine methylation within an Akt consensus phosphorylation motif functions as an inhibitory modification against Akt-dependent survival signaling.

1 April 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KHKeiko Hirota
Keiko Hirota
HDHiroaki Daitoku
Hiroaki Daitoku
HMHitomi Matsuzaki
Hitomi Matsuzaki
NANatsumi Araya
Natsumi Araya
KYKazuyuki Yamagata
Kazuyuki Yamagata
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu
Previous studies have shown that FKHR, a member of the forkhead family of transcription factors, acts as a DNA binding-independent cofactor of nuclear receptors, including estrogen, retinoid, and thyroid hormone receptors, in addition to the original function as a DNA binding transcription factor that redistributes from the nucleus to the cytoplasm by insulin-induced phosphorylation. Here, we demonstrated the physical interaction of FKHR with hepatocyte nuclear factor (HNF)-4, a member of steroid/thyroid nuclear receptor superfamily, and the repression of HNF-4 transactivation by FKHR. FKHR interacted with the DNA binding domain of HNF-4 and inhibited HNF-4 binding to the cognate DNA. Furthermore, the binding affinity of HNF-4 with phosphorylated FKHR significantly decreased in comparison to that with unphosphorylated FKHR. Therefore, a phosphorylation of FKHR by insulin followed by its dissociation from HNF-4 and the redistribution of FKHR from the nucleus to the cytoplasm would expect to induce the transcriptional activation of HNF-4 by facilitating to the access of HNF-4 to its DNA element. Indeed, most intriguingly, insulin stimulation reversed the repression of HNF-4 transcriptional activity by phosphorylation-sensitive (wild-type) FKHR, but not by phosphorylation-deficient FKHR. These results suggest that insulin regulates the transcriptional activity of HNF-4 via FKHR as a signal-regulated transcriptional inhibitor.

1 May 2011 in Cell Metabolism
Verified
Journal Article
Closed access
YTYuta Takahashi
Yuta Takahashi
HDHiroaki Daitoku
Hiroaki Daitoku
KHKeiko Hirota
Keiko Hirota
HTHiroko Tamiya
Hiroko Tamiya
AYAtsuko Yokoyama
Atsuko Yokoyama
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu